I'm tempted into buying at 17.30 a share with a 7.4% yield. Pfizer appears like a steal, but I'm worried about some of the possible underlying problems the industry may face. How much do you think the upcoming expiration of patents will hurt pfizer and will they be able to maintain cash flow? Are there any promising drugs in the development or testing stages? Bottom line: Buy or Sell?
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra